Parkside and medical researchers under contract with Forest Pharmaceutical are enrolling patients in a 20 week clinical trial study to evaluate an investigational drug for the treatment of Bipolar I Disorder. Every day, research uncovers new information about diseases and their treatment. By taking part in a clinical research studay, you can be an important link in testing potential medications for future use.
Who is eligibile?
In 2010 Parkside Presented:
Dr. David Ohlms
In 2009 Parkside Presented:
Dr. Nancy Boyd Franklin
Click here to download the current Parkside Newsletter.
Interested in receiving the Parkside e-Newsletter? Simply submit your information below:
Parkside has a strong commitment to providing excellent service to all of our customers and visitors of this Web site, including respecting your concerns about privacy. Your e-mail address will not be sold or distributed to other entities.